Vaccines, blood, antisera, toxins and cultures in   Germany

Exports In 2023, Germany exported $43.5B in Vaccines, blood, antisera, toxins and cultures, making it the 3rd largest exporter of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 4th most exported product in Germany. The main destination of Vaccines, blood, antisera, toxins and cultures exports from Germany are: United States ($12.4B), Switzerland ($3.82B), Netherlands ($3.16B), Italy ($2.48B), and France ($1.96B).

The fastest growing export markets for Vaccines, blood, antisera, toxins and cultures of Germany between 2022 and 2023 were United States ($3.57B), Austria ($337M), and Belgium ($280M).

Imports In 2023, Germany imported $36.1B in Vaccines, blood, antisera, toxins and cultures, becoming the 2nd largest importer of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 4th most imported product in Germany. Germany imports Vaccines, blood, antisera, toxins and cultures primarily from: United States ($7.08B), Switzerland ($6.79B), Netherlands ($4.88B), Belgium ($4.24B), and Ireland ($4.24B).

The fastest growing import markets in Vaccines, blood, antisera, toxins and cultures for Germany between 2022 and 2023 were United States ($872M), Switzerland ($821M), and Austria ($464M).

COMPANIES In 2023, leading companies such as Amazon (1) were at the forefront of shipping Vaccines, blood, antisera, toxins and cultures from Germany to the United States.